Vioxx Class Action
Introduction
UPDATE (January 19, 2012): We are pleased to announce that a settlement has been reached in this action:
The settlement is for up to $36,881,250.00 depending on the number of approved claims and includes payments to provincial health insurers, payments towards legal costs, and payments for notice and claims administration. If the settlement is approved by the courts, individuals (or their estates) may be eligible to receive payment if they took Vioxx and then experienced a heart attack (myocardial infarction), sudden cardiac death or ischemic stroke. Spouses and children of eligible claimants may also be eligible for payment.
The next step is to seek court approval. A notice with details of the settlement approval hearings will be published in the near future. If the settlement is approved by each of the courts, a further notice will be published which will explain the steps for making a claim.
If you or someone you know used Vioxx and then experienced a myocardial infarction, sudden cardiac death or ischemic stroke, please contact us as soon as possible so we can determine if you are eligible for payment. If the settlement is approved by the courts, there will be a limited time to make a claim and it can take a significant amount of time to get all of the documents necessary to prove your claim.
In October of 1999, Merck Frosst Canada Ltd. and its subsidiaries released Vioxx in the Canadian market. It was described as a new class of drugs called COX-2 inhibitors that could reduce all kinds of pain, especially arthritis, without causing serious gastrointestinal discomfort and bleeding - a risk seen in older drugs like aspirin, Aleve and Advil.
On September 30, 2004 Merck Frosst Canada Ltd. announced the withdrawal of Vioxx. This is the largest worldwide prescription pharmaceutical recall in history. Results from a clinical trial demonstrated that patients who took Vioxx had a higher risk of cardiovascular disease including heart attacks, congestive heart failure, strokes, palpations and death.
Certain internal documents from Merck Frosst Canada Ltd. indicate that Merck Frosst Canada Ltd. was aware that Vioxx doubled the risk of heart attacks and strokes in some patients.
If you or someone you know close to you has taken Vioxx and have experienced cardiovascular disease, heart attacks, strokes or death please complete the “Do you Qualify Form” or “Contact Us” by email. The initial consultation is free and if we accept your case, payment will be on a contingency basis. If we don’t win, you pay no legal fees.
We will do our best to ensure you receive full compensation for your injuries. You have our guarantee.
For more information
Doug Lennox
416.506.1944
dlennox@kleinlyons.com
Meet your